Search Results

GPCR scientist Ben Clements shares how positive allosteric modulators could transform opioid therapy allosteric modulators (PAMs) targeting opioid receptors. Allosteric Modulation: The New Frontier of GPCR Drug Discovery Ben reflects on the emerging potential “Allosteric modulation in GPCRs is so novel and so exciting. allosteric modulators of the mu-opioid receptor.

Since then, he has been studying the allosteric modulation and activation mechanism of this family of activation of cell surface receptors by intracellular proteins; the regulation of GPCRs by both negative and positive allosteric modulators, and the asymmetric functioning of GPCR dimers.

By suppressing glutamate release across circuits in the basal ganglia, mGlu2 is positioned to modulate allosteric modulators The translational gap: why a decade of preclinical mGlu2 evidence has not yet It is also a complication: a receptor that modulates so many circuits will inevitably produce wanted Their answer was yes: a positive allosteric modulator restored mGlu2 signaling even after alcohol-induced allosteric modulator rescues it 09:45 Why mGlu2 is Johnson's receptor of focus: synaptic plasticity

Bruns Fred Bruns discovered the first positive allosteric modulator (PAM) of a GPCR in the late 1980s

<< Back to podcast list Strategic Partner(s) A Brief History of allosteric modulation with Dr. involving autoantibodies and allosteric modulators. model for allosteric modulation, emphasizing the balance between mechanism and empiricism. interactions, specifically allosteric modulation. and allosteric modulation in the context of disease and therapeutic approaches.

Livingston on allosteric opioid modulators, receptor internalization, and navigating the transition from The first allosteric modulators of opioid receptors were discovered through an academic-industry collaboration Scientific Themes of the Conversation Allosteric modulation of opioid receptors - mechanism, selectivity Allosteric opioid modulators bypass the orthosteric site entirely Rather than competing with morphine John Traynor , Kathryn worked to develop and understand first-in-class allosteric modulators of opioid

modulators. modulator, though Fan is careful to note that more thorough characterization is needed before conclusions offer receptor modulation without directly competing with the endogenous agonist at the orthosteric TIMELINE Timestamps are AI-generated approximations based on transcript markers and may not reflect exact positions modulation, and open questions 14:57 - Disease territory: epilepsy, spasticity, pain, addiction, and

Sam Hoare brings a data analyst's perspective to GPCR pharmacology — one trained in allosteric modulation After a PhD on allosteric modulation of dopamine receptors in Philip Strange's UK lab and a postdoc at modulation and the mathematical foundations of receptor theory Biased agonism and constitutive activity modulation of dopamine receptors and the first aha moment 16:53 Why GPCRs? Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors

Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor neuroscience approaches, the Slosky Lab is now working to understand how the principles of receptor allosterism

generation of GPCR pharmacology: the GABA-B heterodimer, the free fatty acid receptors, the unexpected allosteric Her work spans GPCR structural biology, membrane protein stabilization, allosteric modulation, and the modulation and non-orthosteric binding sites on GPCRs Biased agonism, target validation, and animal-to-human modulators bound far outside canonical regions. LMB and the founding of Heptares 11:28 Building a membrane protein team from scratch 15:29 Unexpected allosteric

In his Honours year, Brendan explored small molecule allosteric modulators of the β2-adrenoceptor under Brendan is currently looking for post-doctoral positions to begin in mid-2024" Brendan Wilkins on the

Each session explores mechanistic models, translational challenges, and real-world therapeutic implications Topics frequently address: Receptor efficacy and bias Allosteric modulation PK/PD relationships Irreversible These GPCR webinars focus on conceptual frameworks, models, and translational insight that apply across Topics may include: Receptor efficacy and operational models Allosteric modulators (PAMs and NAMs) Biased They provide exposure to current thinking, advanced modeling approaches, and expert interpretation of

It is a consequence of ligand-dependent receptor conformations and allosteric probe dependence, and it His work is central to the quantitative framework used today to describe receptor signaling bias, allosteric custom products Applications across target identification, HTS, lead optimization, ligand bias and allostery masterclasses with leading researchers Structured networking for scientists and biotech professionals Nonprofit model

steroidogenesis in regulating sexual determination and adrenal and gonadal development using genetic mouse models Slosky characterized a new class of β-arrestin biased allosteric modulators (BAMs) for the neurotensin Critically, these ligands reduce addiction-associated behaviors in animal models without the side effects Because BAMs engage less well-conserved allosteric sites and exert pathway-specific effects on receptor neuroscience approaches, the Slosky Lab is now working to understand how the principles of receptor allosterism

During my post-doctoral research, I was part of a study that identified the receptors of a novel human More recently, I have shifted my focus to identifying allosteric modulators of host G-protein-coupled However, the pursuit of allosteric modulators has gained attention as they have the potential to fine-tune

20th World Congress of Basic and Clinical Pharmacology - Australia GPCR Jobs NEW Open Postdoctoral position and a PhD/post-doc level position - Eli Lilly and Company Postdoctoral Posit ion And PhD Position - affects larval growth and embryonic development in the multivoltine strain of Bombyx more Profiling Allosteric Modulators of CB1R with an Allosteric Fluoroprobe GPCRs in Cardiology, Endocrinology, and Taste Immunolocalization β-arrestin-1/endothelin axis in human ovarian fibroblasts Methods & Updates in GPCR Research Histamine-modulated

Nivedha describes how allosteric signaling within receptors can be quantified at atomic resolution. These residues may represent potential targets for allosteric modulators that reshape receptor signaling Anita Nivedha, a computational biologist studying allosteric communication in GPCRs. Nivedha: One of the main topics I worked on was allosteric communication in proteins. This is what we call allosteric communication.

Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons Interested in orthosteric and allosteric interactions, and still looking for some bias ... anywhere .

receptor heterodimers and the limits of current characterization tools Structural biology of RAMPs - allosteric modulation over direct ligand contact Reproducibility and target validation as prerequisites for meaningful RAMPs Act Allosterically - Not Through Direct Ligand Contact Structural data from the CLR and CTR receptor Their influence on receptor pharmacology appears to be primarily allosteric - subtly reshaping the GPCR fluorescence complementation in vivo 26:42 Structural data and what it reveals about how RAMPs actually modulate

became widely used across the field for measuring receptor-G-protein interactions and screening for allosteric modulators. G proteins had already won their Nobel Prize 12:39 Co-founding CUE Biotech and Caden Biosciences - allosteric modulator screens and G-protein C-terminal peptide tools 17:17 Current receptors: CCR1, FFA2, and muscarinic screen can detect 27:53 The limits of biased agonism - effector context, cell-type dependence, and allosteric

Beaulieu received a Ph.D. in Neurological Sciences from McGill University and completed his post-doctoral The Beaulieu group is presently investigating how cell surface express proteins can act as allosteric modulators of D2R signaling and explores the potential usefulness of beta-arrestins for the development Translational validation is important to validate findings obtained from experimental models research

During these four sessions, you'll dive into: Advanced pharmacokinetic modeling The Druglike Quality ✅ Practical Quantification of Allosteric Modulation – May 1, 2025 ✅ Applying the Black/Leff Operational Model to Predict Agonism – October 2, 2025 Premium Members save 25% on enrollment. Structural Biologist Associate Director/Director, Platform & Hit-ID Chemistry Lead Junior associate position and a PhD/post-doc level position Postdoctoral Position And PhD Position GPCR Molecular Pharmacologist

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology transition to become Dean and his decision to move from Australia to the United States for a postdoctoral position Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK and his experiences of meeting influential figures

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology transition to become Dean and his decision to move from Australia to the United States for a postdoctoral position Postdoctoral Position, Scientific Dynamics, and New Drug Targets Arthur shared his decision to undertake a postdoctoral position with Nigel Bird's lab in the UK and his experiences of meeting influential figures

Fellowship to develop novel methods of synthesizing 2 -imidazoline scaffolds to be used as proteasome modulators Lauren Slosky, she is working to understand the mechanism by which a new class of biased allosteric modulators

Gilman, at the University of Texas Southwestern Medical School as a post-doctoral fellow. The structure was first snapshot of the agonist- and G protein-bound GPCR, providing valuable models We have identified several GPCR ligands that allosterically modulate orthosteric ligand binding and target

Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with His interests are in receptor pharmacology, allosteric protein function, and drug discovery. Dr.

and κ-opioid receptors, and how structural insights can guide the development of new pharmacological modulators biology, membrane protein biochemistry, and pharmacological insights to better understand how ligands modulate protein research GPCR pharmacology and drug discovery strategies Opioid receptor structure and ligand modulation Yamina Berchiche: Unless you start thinking about allosteric modulators. Dr. Joseph Kim: Right—and once you start thinking about allosteric modulation, you open an entirely new set

He is a leader in the study of GPCRs, biased agonism, and also on allosteric interactions between GPCRs

David Hodson Topics Covered: LUXendin probes for GLP-1R labeling across imaging modalities daLUXendin Each session explores mechanistic models, translational challenges, and real-world therapeutic implications GPCR pharmacology, signaling, structural biology, allosteric modulation, biased agonism, assay design